Items where Author is "Forschner, Andrea"
![]() | Up a level |
Article
Reinhard, Soren and Utikal, Jochen Sven and Zaremba, Anne and Lodde, Georg and von Wasielewski, Imke and Klespe, Kai Christian and Meier, Friedegund and Haferkamp, Sebastian and Kahler, Katharina C. and Herbst, Rudolf and Gebhardt, Christoffer and Sindrilaru, Anca and Dippel, Edgar and Angela, Yenny and Mohr, Peter and Pfoehler, Claudia and Forschner, Andrea and Kaatz, Martin and Schell, Beatrice and Gesierich, Anja and Loquai, Carmen and Hassel, Jessica C. and Ulrich, Jens and Meiss, Frank and Schley, Gaston and Heinzerling, Lucie M. and Sachse, Michael and Welzel, Julia and Weishaupt, Carsten and Sunderkotter, Cord and Michl, Christiane and Lindhof, Harm-Henning and Kreuter, Alexander and V. Heppt, Markus and Wenk, Saskia and Mauch, Cornelia and Berking, Carola and Nedwed, Annekathrin Silvia and Gutzmer, Ralf and Leiter, Ulrike and Schadendorf, Dirk and Ugurel, Selma and Weichenthal, Michael and Haist, Maximilian and Fleischer, Maria Isabel and Lang, Berenice and Grabbe, Stephan and Stege, Henner (2025) First-line checkpoint inhibitor therapy in metastatic acral lentiginous melanoma compared to other types of cutaneous melanoma: A multicenter study from the prospective skin cancer registry ADOREG. EUROPEAN JOURNAL OF CANCER, 220: 115356. ISSN 0959-8049, 1879-0852
Reitmajer, Markus and Livingstone, Elisabeth and Thoms, Kai-Martin and Heppt, Markus V. and Meiss, Frank and Gesierich, Anja and Drexler, Konstantin and Heinzerling, Lucie and Meier, Friedegund and Menzer, Christian and Schlaak, Max and Zimmer, Lisa and Forschner, Andrea (2025) Real-world management of patients with complete response under immune-checkpoint inhibition for advanced melanoma. JOURNAL DER DEUTSCHEN DERMATOLOGISCHEN GESELLSCHAFT, 23 (3). p. 329. ISSN 1610-0379, 1610-0387
Leven, Anna-Sophia and Peters, Triinu and Rajcsanyi, Luisa Sophie and Weichenthal, Michael and Mohr, Peter and Meier, Friedegund and von Wasielewski, Imke and Gutzmer, Ralf and Utikal, Jochen and Terheyden, Patrick and Herbst, Rudolf and Haferkamp, Sebastian and Pfoehler, Claudia and Leiter, Ulrike and Forschner, Andrea and Kreuter, Alexander and Gebhardt, Christoffer and Lutze, Stine and Weishaupt, Carsten and Grabbe, Stephan and Debus, Dirk and Hassel, Jessica and Welzel, Julia and Heinzerling, Lucie and Berking, Carola and Loquai, Carmen and Gambichler, Thilo and Ziemer, Mirjana and Becker, Juergen C. and Tasdogan, Alpaslan and Zimmer, Lisa and Livingstone, Elisabeth and Schadendorf, Dirk and Roesch, Alexander and Hinney, Anke and Ugurel, Selma (2025) Sex-specific survival in advanced metastatic melanoma-a DeCOG study on 2032 patients of the multicenter prospective skin cancer registry ADOREG. EUROPEAN JOURNAL OF CANCER, 227: 115668. ISSN 0959-8049, 1879-0852
Forschner, Andrea and Kaehler, Katharina C. and Gschnell, Martin and Langan, Ewan A. and Weishaupt, Carsten and Meiss, Frank and Thoms, Kai-Martin and Wahl, Renate U. and Goeppner, Daniela and Garzarolli, Marlene and Sachse, Michael and Schlaak, Max and Reitmajer, Markus and Kellner, Ivonne and Gesierich, Anja and Mohr, Peter and Meier, Friedegund and von Wasielewski, Imke and Herbst, Rudolf and Utikal, Jochen and Pfoehler, Claudia and Ulrich, Jens and Terheyden, Patrick and Kaatz, Martin and Haferkamp, Sebastian and Leiter, Ulrike and Ugurel, Selma and Weichenthal, Michael and Berking, Carola and Gutzmer, Ralf and Schadendorf, Dirk and Nanz, Lena and Loquai, Carmen (2025) Treatment at the end of life in patients with advanced melanoma. A multicenter DeCOG study of 1067 patients from the prospective skin cancer registry ADOReg. FRONTIERS IN IMMUNOLOGY, 16: 1509886. ISSN 1664-3224,
Zaremba, Anne and Mohr, Peter and Gutzmer, Ralf and Meier, Friedegund and Pfoehler, Claudia and Weichenthal, Michael and Terheyden, Patrick and Forschner, Andrea and Leiter, Ulrike and Ulrich, Jens and Utikal, Jochen and Welzel, Julia and Kaatz, Martin and Gebhardt, Christoffer and Herbst, Rudolf and Sindrilaru, Anca and Dippel, Edgar and Sachse, Michael and Meiss, Frank and Heinzerling, Lucie and Haferkamp, Sebastian and Weishaupt, Carsten and Loeffler, Harald and Kreft, Sophia and Griewank, Klaus and Livingstone, Elisabeth and Schadendorf, Dirk and Ugurel, Selma and Zimmer, Lisa (2023) Immune checkpoint inhibition in patients with NRAS mutated and NRAS wild type melanoma: a multicenter Dermatologic Cooperative Oncology Group study on 637 patients from the prospective skin cancer registry ADOREG. EUROPEAN JOURNAL OF CANCER, 188. pp. 140-151. ISSN 0959-8049, 1879-0852
Haist, Maximilian and Stege, Henner and Rogall, Friederike and Tan, Yuqi and von Wasielewski, Imke and Klespe, Kai Christian and Meier, Friedegund and Mohr, Peter and Kaehler, Katharina C. and Weichenthal, Michael and Hauschild, Axel and Schadendorf, Dirk and Ugurel, Selma and Lodde, Georg and Zimmer, Lisa and Gutzmer, Ralf and Debus, Dirk and Schilling, Bastian and Kreuter, Alexander and Ulrich, Jens and Meiss, Frank and Herbst, Rudolf and Forschner, Andrea and Leiter, Ulrike and Pfoehler, Claudia and Kaatz, Martin and Ziller, Fabian and Hassel, Jessica C. and Tronnier, Michael and Sachse, Michael and Dippel, Edgar and Terheyden, Patrick and Berking, Carola and Heppt, Markus and Kiecker, Felix and Haferkamp, Sebastian and Gebhardt, Christoffer and Simon, Jan Christoph and Grabbe, Stephan and Loquai, Carmen (2023) Treatment management for <i>BRAF</i>-mutant melanoma patients with tumor recurrence on adjuvant therapy: a multicenter study from the prospective skin cancer registry ADOREG. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 11 (9): e007630. ISSN , 2051-1426
Franklin, Cindy and Mohr, Peter and Bluhm, Leonie and Grimmelmann, Imke and Gutzmer, Ralf and Meier, Friedegund and Garzarolli, Marlene and Weichenthal, Michael and Pfoehler, Claudia and Herbst, Rudolf and Terheyden, Patrick and Utikal, Jochen and Ulrich, Jens and Debus, Dirk and Haferkamp, Sebastian and Kaatz, Martin and Forschner, Andrea and Leiter, Ulrike and Nashan, Dorothee and Kreuter, Alexander and Sachse, Michael and Welzel, Julia and Heinzerling, Lucie and Meiss, Frank and Weishaupt, Carsten and Gambichler, Thilo and Weyandt, Gerhard and Dippel, Edgar and Schatton, Kerstin and Celik, Eren and Trommer, Maike and Helfrich, Iris and Roesch, Alexander and Zimmer, Lisa and Livingstone, Elisabeth and Schadendorf, Dirk and Horn, Susanne and Ugurel, Selma (2022) Impact of radiotherapy and sequencing of systemic therapy on survival outcomes in melanoma patients with previously untreated brain metastasis: a multicenter DeCOG study on 450 patients from the prospective skin cancer registry ADOREG. JOURNAL FOR IMMUNOTHERAPY OF CANCER, 10 (6): e004509. ISSN , 2051-1426
Kreft, Sophia and Glutsch, Valerie and Zaremba, Anne and Schummer, Patrick and Mohr, Peter and Grimmelmann, Imke and Gutzmer, Ralf and Meier, Friedegund and Pfoehler, Claudia and Sachse, Michael Max and Meiss, Frank and Forschner, Andrea and Haferkamp, Sebastian and Welzel, Julia and Terheyden, Patrick and Herbst, Rudolf and Utikal, Jochen and Kaatz, Martin and Weishaupt, Carsten and Kreuter, Alexander and Debus, Dirk and Duecker, Pia and Sindrilaru, Anca and Loeffler, Harald and Schley, Gaston and Weichenthal, Michael and Schadendorf, Dirk and Ugurel, Selma and Gesierich, Anja and Schilling, Bastian (2022) MAPKinase inhibition after failure of immune checkpoint blockade in patients with advanced melanoma e An evaluation of the multicenter prospective skin cancer registry ADOREG. EUROPEAN JOURNAL OF CANCER, 167. pp. 32-41. ISSN 0959-8049, 1879-0852
Stege, Henner and Haist, Maximilian and Schultheis, Michael and Fleischer, Maria Isabel and Mohr, Peter and Meier, Friedegund and Schadendorf, Dirk and Ugurel, Selma and Livingstone, Elisabeth and Zimmer, Lisa and Herbst, Rudolf and Pfoehler, Claudia and Kaehler, Katharina and Weichenthal, Michael and Terheyden, Patrick and Nashan, Dorothee and Debus, Dirk and Kaatz, Martin and Ziller, Fabian and Haferkamp, Sebastian and Forschner, Andrea and Leiter, Ulrike and Kreuter, Alexander and Ulrich, Jens and Kleemann, Johannes and Bradfisch, Fabienne and Grabbe, Stephan and Loquai, Carmen (2021) Discontinuation of BRAF/MEK-Directed Targeted Therapy after Complete Remission of Metastatic Melanoma-A Retrospective Multicenter ADOReg Study. CANCERS, 13 (10): 2312. ISSN , 2072-6694
Heppt, Markus V. and Heinzerling, Lucie and Kaehler, Katharina C. and Forschner, Andrea and Kirchberger, Michael C. and Loquai, Carmen and Meissner, Markus and Meier, Friedegund and Terheyden, Patrick and Schell, Beatrice and Herbst, Rudolf and Goeppner, Daniela and Kiecker, Felix and Rafei-Shamsabadi, David and Haferkamp, Sebastian and Huber, Margit A. and Utikal, Jochen and Ziemer, Mirjana and Bumeder, Irmgard and Pfeiffer, Christiane and Schaed, Susanne G. and Schmid-Tannwald, Christoph and Tietze, Julia K. and Eigentler, Thomas K. and Berking, Carola (2017) Prognostic factors and outcomes in metastatic uveal melanoma treated with programmed cell death-1 or combined PD-1/cytotoxic T-lymphocyte antigen-4 inhibition. EUROPEAN JOURNAL OF CANCER, 82. pp. 56-65. ISSN 0959-8049, 1879-0852
Conference or Workshop Item
Schadendorf, Dirk and Richtig, Erika and Loquai, Carmen and Forschner, Andrea and Gutzmer, Ralf and Haferkamp, Sebastian and Utikal, Jochen and Hassel, Jessica Cecile and Meier, Friedegund and Debus, Dirk and Fluck, Michael and Goeppner, Daniela and Kehrer, Helmut and Dummer, Reinhard and von Moos, Roger and Thompson, Jan and Gengenbacher, Laura and Michielin, Olivier and Hoeller, Christoph (2022) Encorafenib plus binimetinib in patients with locally advanced, unresectable or metastatic BRAFV600-mutated melanoma: an ongoing multi-centric, multi-national, prospective, longitudinal, non-interventional study - BERING-Melanoma. In: 35. Deutscher Krebskongress, Krebsmedizin: Schnittstellen zwischen Innovation und Versorgung, 13.–16. November 2022, Berlin.
Richtig, Erika and Loquai, Carmen and Forschner, Andrea and Gutzmer, Ralf and Hassel, Jessica Cecile and Utikal, Jochen and Haferkamp, Sebastian and Meier, Friedegund Elke and Debus, Dirk and Dummer, Reinhard and Von Moos, Roger Anton Fredy and Thompson, Jan and Gengenbacher, Laura and Michielin, Olivier and Hoeller, Christoph and Schadendorf, Dirk (2022) Encorafenib plus binimetinib in patients with locally advanced, unresectable, or metastatic BRAF(V600)-mutant melanoma: Updated data from the multicenter, multinational, prospective, non-interventional longitudinal study BERING(MELANOMA). In: Annual Meeting of the American Society of Clinical Oncology (ASCO), June 03-07, 2022, Elec Network.
Richtig, Erika and Gutzmer, Ralf and Loquai, Carmen and Utikal, Jochen and Hoeller, Christoph and Stadler, Rudolf and Forschner, Andrea and Hassel, Jessica Cecile and Goeppner, Daniela and Fluck, Michael and Haferkamp, Sebastian and Kaatz, Martin and Welslau, Manfred and Dummer, Reinhard and Von Moos, Roger Anton Fredy and Schmidt, Andrea and Milde, Laura and Michielin, Olivier and Schadendorf, Dirk (2021) Encorafenib plus Binimetinib in patients with locally advanced, unresectable or metastatic BRAF(V600)-mutant melanoma: First data of the multicenter, multinational, prospective, non-interventional longitudinal study BERING(MELANOMA). In: 2021 ASCO Annual Meeting, 4. Juni - 8. Juni 2021, Online.

